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Summary Autoimmune diseases reveal complex and multigenic phenotypes affected by a
variety of genetic and environmental or stochastic factors. A lot of models for autoimmune
diseases including Sjo¨gren’s syndrome (SS) have been demonstrated using gene-manipulated or
other animals. Previous findings obtained with both animal models and patients with SS indicate
involvement of a Tcell with a T helper type 1 (TH1) phenotype. This review focuses on the Tcell-
dependent autoimmune disease such as SS to understand the molecular mechanism of regulation
of T cell activation in autoimmunity, and highlights the pathogenesis of autoimmune disease.
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Our body is protected by precise immune system consisted of
a number of immune cells which play each roles in main-
tenance for various immune responses. Among them, T cells
play a central role in both cellular and humoral immunity [1].
After antigenic stimulation, naı¨ve T cells proliferate and
differentiate into various effector subsets characterized by
the production of distinct cytokines and by their distinct
effector functions [2]. Although almost autoimmune diseases
occur through the pathogenesis based on CD4+ Tcell dysfunc-
tion or failure of differentiation in the thymus or peripheral
lymphoid organs, the precise mechanism how autoreactive T
cell emerges has been still unclear. In this review, we outline
current information as to the association of T cell regulation
with autoimmunity, and indicate the molecular mechanism
for pathogenesis of SS, an organ-specific autoimmunie dis-
ease in salivary glands.* Corresponding author. Tel.: +81 88 633 7464; fax: +81 88 633 7464.
E-mail address: ishimaru@dent.tokushima-u.ac.jp (N. Ishimaru).
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The CD4+ Tcells were designated TH1 cells, characterized by
the secretion of interleukin (IL)-2 and interferon (IFN)-g but
not IL-4 and IL-5, and T helper type 2 (TH2) cells, which were
characterized by the secretion of IL-4 and IL-5 but not IL-2 or
IFN-g (Fig. 1). TH1 cells elicit delayed-type hypersensitivity
responses, activate macrophages and are highly effective in
clearing intracellular pathogens [3]. By contrast, TH2 cells
are crucial for the production of immunoglobulin E and
eosinophilic inflammation such as allergic diseases and
may suppress cell-mediated immunity [4]. Besides, several
subsets of regulatory T (Treg) cells capable of controlling
effector T cells have been well known [5]. Furthermore,
recent reports have demonstrated that T helper 17 (TH17)
cells as a new subset produce IL-17, and are involved in the
various immune responses [6]. Dysregulated or uncontrolled
effector T cell responses lead to autoimmune disease, sug-
gesting that breakdown of central or peripheral tolerance
induces dysfunction of Tcell subsets and then the onset of any
autoreactive response.l Science. Published by Elsevier Ireland. All rights reserved.
Figure 1 Differentiation of CD4+ T cell lineages. Peripheral
naı¨ve CD4+ T cell precursor cells can differentiate into three
subsets of effector T cells and several subsets of Treg cells. Each
subset is associated with the pathogenesis of many immune
disorders.
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to the induction and progression of a lot of autoimmune
diseases in human or animal models [4,7,8]. On the other
hand, it has been reported that TH17 cells play an important
role in the pathogenesis of autoimmune diseases such as
rheumatoid arthritis (RA), multiple sclerosis, systemic lupus
erythematous (SLE) and asthma [6]. Moreover, it is well
known that natural CD25+CD4+ Treg cells are one of key
subsets for inducing or attenuating immunological tolerance
to self or non-self antigens [5]. For instance, depletion or
dysfunction of natural CD25+CD4+ Treg cells suffices to cause
autoimmune disease in normal mice by administration of
neutralizing antibody against CD25 molecule [9]. Also, pre-
ventive or therapeutic effects by adoptive transfer of
CD25+CD4+ Treg cells into autoimmune models were demon-
strated in previous reports [10]. Thus, the T cell-dependent
autoimmune diseases are occurred based on the breakdown
of proportion or function of T cell subsets in the immune
system.
SS is an autoimmune disorder characterized by lympho-
cytic infiltrates and destruction of salivary and lacrimal
glands (Fig. 2), leading to clinical symptoms of dryness of
the mouth and eyes (sicca syndrome) which may predispose
patients to oral or ocular infections [11]. In the salivary gland
tissues from SS patients, predominance of CD4+ T cells in
addition to a small number of CD8+ T cells, B cells, orFigure 2 Pathology of salivary gland tissues from SS patients. A Lym
SS patients was observed. Lip biopsy materials were used for staining
Immunohistochemical staining of CD3+ T cells was performed usingmacrophages is observed. It is well known that TH1 cells
producing IL-2 and IFN-g play a central role in the onset of
both human SS and the animal models [7,8,12,13].
3. Autoimmune models
Why do self-T cells attack self-tissues, cells or antigens?
Analyzing animal models is useful to understand the patho-
genesis or mechanism of human autoimmune disease. The
three types of animal models for autoimmune diseases are
known. The first is the type of autoimmune prone animals
that any autoimmune diseases are naturally appeared,
including NOD mouse of a model for autoimmune diabetes
(type I DM), MRL/lprmouse of amodel for RA and SLE [14,15].
These mice have often been used for analyzing the patho-
genic mechanism as the lesions are naturally occurred, and
the incidence of disease onset is relatively constant com-
pared with the other models. The second is drug-induced or
operation-induced models such as the autoimmune model in
multiorgans by injection of neutralizing antibody against
CD25 as mentioned above or a murine SS model by neonatal
thymectomy for NFS/sldmouse [6,12]. Although the handling
or manipulating these models is difficult, it is useful to
analyze the autoimmune lesions during short term. The third
is a type of gene-manipulated animal including any gene
knockout (KO) or transgenic (TG) mice. These models are
helpful to define the molecular mechanism of autoimmune
diseases.
For instance, a number of murine models showing SS-like
autoimmune lesions have been reported as shown in Table 1.
The (NZB/NZW)F1 mouse was one of the first models of
spontaneous SS [16]. NOD and MRL/lpr mice have been
described to be models for the secondary SS besides the
lesions of autoimmne diabetes, or RA and SLE [14,15]. The
secondary SS in human is also known to accompany with RA,
SLE, or the other autoimmune diseases [11]. Additionally,
although aly/aly mouse bearing a mutant of NF-kB-inducing
kinase (NIK) gene has been reported to be an SS model,
autoimmune lesions are observed in multiorgans other than
salivary glands [17]. As a model for the primary SS, the NFS/
sld mouse thymectomized on 3-day after birth has been
established [12]. We have analyzed the model to detectphocytic infiltration with tissue destruction in salivary gland from
with hematoxylin and eosin. A representative photo is shown. B
the paraffin-embed sections of salivary glands from SS patients.
Table 1 Representative murine models for human SS.
Year [Ref. no.] Mouse Related data
1979 [16] NZB/NZW F1 Ro60, IFN-g
1983 [14] MRL/lpr Fas, RA, SLE
1989 [27] HTLV-1 tax TG Human T cell leukemia
1992 [15] NOD Type I DM
1994 [12] NFS/sld thymectomy, a-fodrin
1996 [20] TGF-b1 KO IFN-g
1996 [17] aly/aly NIK
1999 [21] IL-10 TG FasL
2002 [23] AIRE KO autoantigens
2004 [29] Aromatase KO a-fodrin
2004 [25] Id3 KO T cell development
2006 [26] ClassIA PI3K KO SSA, IFN-g, Treg
2006 [22] IL-14a TG Aging, CD5+B cell
2006 [24] CCR7 KO thymic T cell selection
2006 [28] NZW2328 MCMV
2008 [30] RbAp48 TG estrogen
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antigen-specific response of TH1 cells, and define the break-
down of peripheral tolerance by dysfunction of activation-
induced cell death (AICD) that is a system to delete auto-
reactive Tcells in the periphery [18,19]. Besides, several KO
mice have been reported that SS-like lesions are observed in
salivary or lacrimal glands. Cytokine gene-manipulated mice
such as TGF-b1 KO, IL-10 TG, or IL-14a TG mice have been
reported to be spontaneous SS models [20—22]. Also, the SS-
like lesions have been indicated in some KO mice for auto-
immune regulator (AIRE) [23], a transcription factor as known
to be important for the expression of autoantigen in thymus,
or C-C chemokine receptor 7 (CCR7), a chemokine receptor
for CCL19 and CCL21, which plays a crucial role in the T cell
selection in thymic medulla [24]. Also, in the KO mice for Id3
and class IA phosphoinositide-3-kinase (PI3K) which are
related to differentiation or function of immune cells includ-
ing Tcells, inflammatory lesions of salivary or lacrimal glands
were reported [25,26]. On the other hand, SS-like lesions
were induced by transgene of virus-related antigen or virus
infection [27,28]. As for environmental factor such as hor-
mone, autoimmne lesions of salivary glands from aromatase
KO mice are observed [29]. Recently, we have established
retinoblastoma-associated protein 48 (RbAp48) TG mouse as
one of SS models in which transgenic expression of RbAp48 in
the salivary glands resulted in the development of autoim-
mune exocrinopathy resembling SS [30]. These studies using
several SS models raise the new findings as to not only the
pathogenesis of SS, but also the molecular mechanisms for
central or peripheral T cell tolerance in the immune system.
4. Transcription factors in pathogenesis of
autoimmunity
What is happening to the inside of T cell in autoimmune
response? Several transcription factors controlling target
genes essential for cell survival, cytokine production, che-
mokine production, adhesion molecule expression, organo-
genesis, and apoptosis play central roles in T cell activation
[31]. Among them, nuclear factor (NF)-kB plays a key role inregulating many inflammatory processes of T cells [32,33].
NF-kB has five subunits including NF-kB1 (p50 and its pre-
cursor p105), NF-kB2 (p52 and its precursor p100), RelA
(p65), RelB, and c-Rel.
Antigenic stimuli from T cell receptor (TCR), co-stimula-
tory molecules such as CD28, and cytokine receptors leads to
NF-kB activation through a lot of signal molecules. Two main
pathways of NF-kB are well known. One is the classical
pathway (canonical pathway) through complex of NF-kB1
and RelA [34,35]. The other pathway is through complex of
NF-kB2 and RelB (non-classical pathway, non-canonical path-
way, or alternative pathway) [34,35]. Signals from TCR and
CD28 through many adaptor molecules lead to protein kinase
C (PKC) activation. Downstream of PKC, there is CARMA1/
MALT1/Bcl-10, which activate IkB kinase (IKK). IKK phosphor-
ylates IkB, which binds to NF-kB complex in the cytoplasm to
inhibit nuclear translocation. Ubiquitination and degradation
of IkB can induce transport of NF-kB complex into the
nucleus. As a result, NF-kB complexes control transcription
of the target genes essential for Tcell activation. Also, signals
from TCR/CD28 or cytokine receptors lead to PKC, NIK, and
CARMA1/MALT1/Bcl-10. Activation of IKK processes p100 into
p52, and complex of p52 and RelB is translocated into the
nucleus to regulate transcription of the target genes. It has
been reported that the classical pathway of NF-kB is essential
for innate immunity [36,37]. Moreover, many data suggest
that the alternative pathway plays a central role in the
expression of genes involved in development and mainte-
nance of secondary lymphoid organs [35]. Non-classical path-
way of NF-kB has been described that is independent of IKKg
and involves the processing of the p100 precursor to p52,
which is triggered by the phosphorylation of p100 by the NIK
and IKKa [36,37]. In addition, the importance of several
signal molecules for NF-kB activation including NIK, IKKs,
and IkBs has been highlighted with several mouse models
[31]. The most important phenotype for aly/aly, and NIK KO
mice is autoimmune disease in multiorgans including lacrimal
gland, salivary gland, lung, liver, kidney, and pancreas [17].
Our study demonstrates that proliferative response of
naı¨ve CD4+ T cells from aly/aly, NIK KO, RelB KO mice, but
not memory T cells, is higher than that from control mice,
suggesting that NF-kB2 deficiency might result in the hyper-
proliferation of naı¨ve Tcells to respond to any self-proteins to
induce autoimmune disease [38].
The processing of NF-kB2/p100 to p52 is controlled by a
kinase cascade including activation of IKKa through NIK.
Based on our research, the main NF-kB complex p50-RelA
for normal naı¨ve CD4+ T cell activation might be retained in
the cytoplasm to interact with p100 [38]. It is possible that
over-activation of naı¨ve CD4+ T cells would be regulated by
the interaction between NF-kB1 (p50)-p65 and NF-kB2 (p100)
to inhibit nuclear translocation of p50-p65 dimmers as shown
in Fig. 3. This possibility corresponds to a previous data which
accumulated p100 of activated osteoclasts from NIK KO mice
would bind NF-kB1-RelA subsets to prevent their nuclear
transport and inhibit osteoclastogenesis [39].
When naı¨ve T cells of aly/aly mice were transferred into
Rag2 KOmice which have no Tand B cells in the periphery, the
severe autoimmune lesions in lacrimal glands, lung, and
salivary glands were observed [38]. Therefore, it is possible
that NF-kB2-deficient T cells may be hyperreactive to any
self-antigen through excessive activation of NF-kB1/RelA
Figure 3 Novel regulation mechanism of NF-kB by the non-
classical NF-kB pathway. Stimuli from T cell receptor (TCR),
CD28, or cytokine receptors lead to phospolyration, ubiqutina-
tion, and degradation of IkB following nuclear transport of NF-
kB1/RelA complex. After regulation by IkB, NF-kB2/RelB com-
plex binds to the NF-kB1/RelA complex to control the transloca-
tion into the nucleus.
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cell regulation in autoimmunity.
5. Conclusion
Based on previous reports as mentioned above, TH1 cells play
a central role in the pathogenesis for SS in human and the
animal models. Our studies and the other reports have
demonstrated that apoptosis of Fas-expressing salivary gland
cells stimulated by cytokines which TH1 cells secreted was
undergone by interaction with Fas ligand (FasL)-expressing
activated T cells [19,21]. However, it is still unclear why
salivary or lacrimal glands are attacked as a target organ. The
breakdown of T cell tolerance via disorders of signaling
molecules for T cell activation such as NF-kB may tend to
induce autoimmune lesions in salivary and lacrimal glands
resembling human SS, suggesting that salivary or lacrimal
gland cells are much more sensitive to any cytokines or
stimulation factors from autoreactive and pathogenic Tcells.
We hypothesize that there may be a unique system ‘‘local
immune tolerance’’ in salivary and lacrimal glands [30]. With
the loss of local immune tolerance by any change of immune
homeostasis, the salivary and lacrimal gland cells might
become target cells toward autoreactive Tcells. It is possible
that there are complex mechanisms including expression of
autoantigen, MHC class II, or any molecules related with
autoimmunity of the target cells for triggering autoimmune
disease.
Considerable progress has been made in elucidating the
immunological events surrounding autoimmune disease.Despite such progress, however, a lot of important critical
issues remain to be addressed. Additional advances will
come from further studies of experimental models or
human patients to address specific aspects of the disease.
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